CardioPractice Cardio Talk

With Konstantinos Toutouzas and Charalambos Vlachopoulos, First Department of Cardiology of the National & Kapodistrian University of Athens - Greece.  Konstantinos Toutouzas and Charalambos Vlachopoulos discuss cardiac amyloidosis.  

With Riccardo Asteggiano, Faculty of Medicine, Insubria University, Varese, and LARC (Laboratorio Analisi Ricerca Clinica), Turin - Italy, and José Fernando Rodriguez Palomares, Vall d’Hebron University Hospital, Barcelona - Spain.   In this podcast, José Fernando Rodriguez Palomores joins Riccardo Asteggiano to discuss the new 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases, focusing on aortic aneurysms.

With Thomas F. Luscher, ESC President, Royal Brompton Hospital Imperial College London - UK and Center for Moelcular Cardiology, University of Zurich - Switzerland, and Marc Ferrini,  Editor-in-Chief Cardio Practice, CH Saint Joseph and Saint Luc, Lyon - France.   In this podcast, Thomas F. Luscher joins Marc Ferrini to discuss his plans and vision for the future in his new role as President of the ESC.

With Ruxandra Maria Christodorescu, University of Medicine and Pharmacy Victor Babes, Timisoara - Romania and Eva Gerdts, University of Bergen - Norway.   In this podcast, Eva Gerdts joins Dr Ruxandra Christodorescu to discuss essential hypertension from the 2024 Guidelines for the management of elevated blood pressure and hypertension (https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehae178/7741010).

With Tiziana Claudia Aranzulla, MD, MSC, Mauriziano Umberto Hospital, Turin - Italy, and Riccardo Asteggiano, MD, FESC, Laboratorio Analisi Ricerca Clinica, Turin - Italy.   In this podcast, Tizania Claudia Aranzulla joins Riccardo Asteggiano to discuss acute coronary syndrome in elderly and frail patients.

In this interview with Borja Ibáñez, National Centre for Cardiovascular Research CNIC and Fundacion Jimenez Diaz Hospital, Madrid - Spain, one of the Task Force co-ordinators of the ESC 2023 Guidelines for the management of acute coronary sydromes, and Riccardo Asteggiano, Laboratorio Analisi Ricerca Clinica, Turin - Italy, underline the complex aspects of long-term therapy after ACS, mainly concerning antithrombotic management and secondary prevention management.

With Bernard Iung, Hospital Bichat-Claude Bernard, Paris - France & Konstatinos Toutouzas, National & Kapodistrian University of Athens, Athens - Greece. In this podcast, they discuss primary mitral regurgitation.

With Maurice Enriquez-Sarano, The Allina Heart Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, MN & Marc Ferrini2, CH Saint Joseph and Saint Luc, Lyon, France. In this podcast, Dr Maurice Enriquez-Sarano (The Allina Heart Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, MN, USA) joins Dr Marc Ferrini (Editor-in-Chief CardioPractice; CH Saint Joseph and Saint Luc, Lyon, France) to discuss our current understanding of mitral valve prolapse (MVP). The treatment of MVP has evolved in recent years, and we now know that a small fraction of myxomatous mitral valve prolapse patients may, over time, experience severe arrhythmia, irrespective of mitral regurgitation severity. Dr Sarano presents the current thinking on the diagnosis and the tools available for arrhythmic risk stratification.

With Panos E. Vardas, Department at Heraklion University, Hospital, Crete - Greece & Marc Ferrini, Editor-in-Chief CardioPractice; CH Saint Joseph and Saint Luc, Lyon - France. In this podcast, Professor Panos E. Vardas (Department at Heraklion University, Hospital, Crete, Greece) joins Dr Marc Ferrini (CH Saint Joseph and Saint Luc, Lyon, France) to discuss how artificial intelligence can modify our daily cardiology practice.

With Dimitris RICHTER, Euroclinic of Athens, Athens - Greece & Heinz DREXEL, Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch - Austria. In this podcast, Professor Heinz Drexel (Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch, Austria) joins Dr Dimitris Richter (Euroclinic of Athens, Athens, Greece) to discuss hypertriglyceridemia and residual cardiovascular risk.   Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. N Engl J Med. 2022 Nov 24;387(21):1923-1934. Sosnowska B, Adach W, Surma S, Rosenson RS, Banach M. Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. J Clin Med. 2022 Dec 25;12(1):168. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821629/ Gaba P, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Tardif JC, Giugliano RP, Martens FMAC, Gibson CM, Ballantyne CM; REDUCE-IT Investigators. Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction. J Am Coll Cardiol. 2022 May 3;79(17):1660-1671. https://www.sciencedirect.com/science/article/pii/S0735109722005538?via%3Dihub Drexel H, Tamargo J, Kaski JC, Lewis BS, Saely CH, Fraunberger P, Dobrev D, Komiyama M, Plattner T, Agewall S, Hasegawa K. Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease? Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20;9(6):570-582. https://academic.oup.com/ehjcvp/article/9/6/570/7199773?login=false ACCORD Study Group; Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010 Apr 29;362(17):1563-74. https://www.nejm.org/doi/10.1056/NEJMoa1001282?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov